Rejecting the allegations of non-disclosure of segregated clinical data and haste in granting approval to Covaxin and Covishield, the two main Covid vaccines approved by the government, the SC said the results of Phase III clinical trials of these vaccines have been published, in line with the requirement under the statutory regime in place, the … Read more
Seventy per cent of the people who received a booster dose of the Covid vaccine did not contract the disease during the third wave, according to a new study that covered around 6,000 people in India. The study led by Dr Rajeev Jayadevan, co-chairman of the Indian Medical Association’s national task force on coronavirus, said … Read more
The Serum Institute of India has urged the Centre to use the available 10 crore doses of Covishield offered free of cost by GAVI under COVAX facility in view of rising COVID-19 cases in the country, an official source said. The Pune-based firm has written to the Ministry of Health and Family Welfare (MoHF) that … Read more
Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months at present to safeguard people against emerging COVID variants, according to its CEO Adar Poonawalla. Recalling that they could not meet the commitment of exporting vaccines in … Read more
A day before the Covid-19 booster shoot drive is rolled out, both major vaccine manufacturers went on to announce a massive price cut on their vaccines. The Covid-19 vaccines Covishied which is manufactured by the Serum Institute of India and Covaxin from Bharat Biotech earlier used to cost Rs 600 and Rs 1200 respectively, but … Read more
Serum Institute of India has cut the price of the Covishield precaution (booster) dose at private hospitals by more than half, a day before booster shots become available to all Indian adults, CEO Adar Poonawalla announced. The price of a single dose has been slashed to Rs 225 from Rs 600 earlier. The decision was … Read more
Under the national Covid-19 vaccination programme, the second dose of the Covishield is currently being administered 12-16 weeks after the first dose. The government’s National Technical Advisory Group on Immunisation (NTAGI) has recommended a reduction in the gap between the first and second dose of Covishield Covid-19 vaccine in the country. The dosage interval for … Read more
India is yet to approve the use of intranasal vaccine against COVID-19, BBV154 developed by the Hyderabad based company. The AIIMS will start the booster dose trial of Bharat Biotech’s intranasal COVID-19 vaccine from Friday. The booster dose will be given to those who have received both the doses of either Covaxin or Covishield at … Read more
Poonawalla was speaking at a felicitation ceremony organised for him by the Mahratta Chamber of Commerce, Industries and Agriculture in Pune. Serum Institute of India’s chairman and MD Cyrus Poonawalla on Monday said his company works with the goal to sell vaccines at the price of a cup of tea and make them affordable for … Read more
The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late in the night, it said. India’s COVID-19 vaccination coverage has crossed 167.80 crore with over 48 lakh vaccine doses being administered on Wednesday, the Union Health Ministry said. The daily vaccination tally is expected to … Read more